Related Experiment Video

Updated: Mar 6, 2026

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

7.4K

Signaling pathways as therapeutic targets in biliary tract cancer

Jennifer Yang1, Matthew R Farren2, Daniel Ahn3

  • 1a Molecular Cellular and Developmental Biology Graduate Program , The Ohio State University , Columbus , OH , USA.

Expert Opinion on Therapeutic Targets
|March 11, 2017
PubMed
Abstract

Insights

Biliary tract cancer (BTC) treatment needs novel approaches. Targeting key pathways like MEK, PI3K, and STAT3 shows promise for improving outcomes in advanced BTC.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Biliary tract cancer (BTC) incidence is rising, often diagnosed at advanced stages with poor survival.
  • Current treatment options for BTC are limited, necessitating novel therapeutic strategies.
  • Chemotherapy offers marginal benefit, driving interest in targeted therapies.

Purpose of the Study:

  • To review current chemotherapeutic regimens for BTC.
  • To highlight key signal transduction pathways for targeted inhibition in BTC.
  • To discuss promising inhibitors of MEK, PI3K, and STAT3 pathways.

Main Methods:

  • Literature review of clinical trials and pre-clinical data on BTC treatments.
  • Focus on signal transduction pathways: MEK/MAP2K, PI3K, and STAT3.
  • Analysis of available data on inhibitors targeting these pathways.

Main Results:

  • Chemotherapy provides limited efficacy in BTC treatment.
  • MEK, PI3K, and STAT3 pathways are crucial targets for BTC therapy.
  • Several inhibitors targeting these pathways show promise in pre-clinical and clinical studies.

Conclusions:

  • Future BTC treatment strategies should incorporate targeted therapies.
  • Targeting MEK, PI3K, and STAT3 pathways is a key future direction.
  • Combined therapeutic approaches focusing on these targets are recommended for BTC.
Keywords:
Biliary tract cancerMEKPI3KSTAT3cholangiocarcinomatargeted therapy

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.8K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.6K